Vera Therapeutics, Inc. (VERA)
NASDAQ: VERA · Real-Time Price · USD
45.36
+1.54 (3.51%)
Nov 4, 2024, 12:59 PM EST - Market open
Vera Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 4, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 2,487 | 683 | 535 | 569 | - | - |
| Market Cap Growth | 178.59% | 27.69% | -5.87% | - | - | - |
| Enterprise Value | 2,071 | 553 | 433 | 482 | - | - |
| Last Close Price | 43.82 | 15.38 | 19.35 | 26.72 | - | - |
| PE Ratio | - | -6.84 | -5.77 | -11.01 | - | - |
| PB Ratio | 7.33 | 6.72 | 6.96 | 8.17 | - | - |
| P/FCF Ratio | -18.52 | -7.41 | -7.91 | -23.98 | - | - |
| P/OCF Ratio | -18.54 | -7.41 | -7.92 | -23.98 | - | - |
| EV/EBITDA Ratio | - | - | -4.77 | -14.09 | - | - |
| EV/EBIT Ratio | -13.89 | -5.42 | -4.76 | -14.02 | - | - |
| EV/FCF Ratio | -15.24 | -5.99 | -6.40 | -20.34 | - | - |
| Debt / Equity Ratio | 0.16 | 0.53 | 0.41 | 0.07 | - | 0.04 |
| Debt / FCF Ratio | -0.49 | -0.58 | -0.46 | -0.21 | - | -0.01 |
| Quick Ratio | 20.98 | 7.21 | 4.48 | 10.36 | 22.36 | 3.05 |
| Current Ratio | 21.43 | 7.71 | 4.91 | 10.73 | 22.55 | 3.36 |
| Return on Equity (ROE) | -46.05% | -107.50% | -121.58% | -54.43% | -198.65% | - |
| Return on Assets (ROA) | -24.74% | -41.54% | -52.81% | -31.09% | -102.70% | - |
| Return on Capital (ROIC) | -26.58% | -48.38% | -62.19% | -34.47% | -114.19% | - |
| Earnings Yield | -4.49% | -14.05% | -16.64% | -5.74% | - | - |
| FCF Yield | -4.45% | -13.50% | -12.64% | -4.17% | - | - |
| Buyback Yield / Dilution | -42.08% | -60.73% | -97.76% | -4099.14% | -8.34% | - |
| Total Shareholder Return | -42.08% | -60.73% | -97.76% | -4099.14% | -8.34% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.